Close

Johnson & Johnson to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...
Johnson & Johnson will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, at the Terranea in Rancho Palos Verdes, CA.  Dominic Caruso, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
 
Press Contacts:
Ernie Knewitz
(732) 524-6623
(917) 697-2318 (M)
 
Amy Jo Meyer
(732) 524-6678
(908) 616-6250 (M)
 
Investor Contacts:
Louise Mehrotra
(732) 524-6491
 
Jason Valmore
(732) 524-3709

Latest stories

Related stories

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back